By Karen Roman Imviva Biotech said it has FDA authorization for its Investigational Device Exemption application to use Adaptive Biotechnologies’ clonoSEQ assay in the TENACITY-01 trial to treat leukemia/lymphoma and minimal residual disease. This authorization enables the company to use...

  Tech Edge hosted a fireside chat on June 9 at Pax8 Beyond 2026 in Salt Lake City with Rob Belgrave, Chief Business Officer at Pax8, and Steve Stone, Chief Customer Officer at SentinelOne, Inc. (NYSE: S). The in-person interview was joined...

Watch Video Highlights Below, or Click HERE:  Tech Edge hosted a fireside chat on June 8 at Pax8 Beyond 2026 in Salt Lake City with Renee McCloden, Global Senior Director of Vendor Strategy and Programs at Pax8, and Tim Barton-Wines, Chief...

Watch Video Highlights Below, or Click HERE:  Tech Edge hosted a fireside chat on June 9 at Pax8 Beyond 2026 in Salt Lake City with Ryan Walsh, co-founder, Chief Strategy Officer and Channel Chief at Pax8, and Nyssa Waters, co-founder and...

By Karen Roman Candel Therapeutics, Inc. (Nasdaq: CADL) said it appointed Mark Sims as Chief Commercial Officer effective July 6, 2026, having previously served at AstraZeneca as Vice President and Global Franchise Head, where he directed the commercial strategy for...

Watch Video Highlights Below, or Click HERE:  Tech Edge hosted a fireside chat on June 9 at Pax8 Beyond 2026 in Salt Lake City with Craig Foster, Chief Financial Officer at Pax8. The in-person interview was joined by Editor-in-Chief John Jannarone...

Watch Video Highlights Below, or Click HERE:  Tech Edge hosted a fireside chat on June 8 at Pax8 Beyond 2026 in Salt Lake City with Ryan Walsh, Co-Founder, Chief Strategy Officer and Channel Chief at Pax8, and Jen Bodell, Corporate Vice...

By Karen Roman Nextech3D.AI Corp. (OTCQX: NEXCF | CSE: NTAR | FSE: EP2) said fourth quarter total revenue soared 207% to $939,000 compared to the year prior. Gross profit grew 263% to reach $858,000 in the fourth quarter compared to...

Watch Video Highlights Below, or Click HERE:  Tech Edge hosted a fireside chat on June 9 at Pax8 Beyond 2026 in Salt Lake City with Kristen Fehrenbach, Vice President of Global Microsoft Alliance at Pax8, and Michelle Curtis, Chief Revenue Officer at New Charter...

By Daniella Parra VERAXA Biotech AG (Nasdaq: VRXA)has expanded its R&D facility in Heidelberg, Germany, increasing laboratory space by more than 60% to support team growth and accelerate its cancer therapy programs toward clinical development, the company said. The expansion...